An Extension Study to MEA115661 in Severe Asthma

• Research type

  Research Study

• Full title

  Study 201312: A Multi-Centre, Open-Label, Study of Mepolizumab in a Subset of Subjects with a History of Life Threatening/Seriously Debilitating Asthma Who Participated in the MEA115661 Trial

• IRAS ID

  152568

• Contact name

  Chris Brightling

• Contact email

  ceb17@le.ac.uk

• Sponsor organisation

  GSK

• Eudract number

  2014-000314-54

• REC name

  East Midlands - Nottingham 2 Research Ethics Committee

• REC reference

  14/EM/0143

• Date of REC Opinion

  23 May 2014

• REC opinion

  Further Information Favourable Opinion